💬 In the latest episode of #BeyondtheBiopsy, Drs. @NitinYerram and Kyrollis Attalla (@KAttallaMD), draw on data from clinical trials—such as the ProBE‑PC trial—during their conversation on the growing shift from transrectal to transperineal techniques in #prostatecancer: https://t.co/L24GRYmtfh
Kudos to @NitinYerram for an incredible initiative! High-yield discussions for patients and providers. Looking forward to future episodes! Big thanks to him and @GUOncologyNow for the invitation! @MountsinaiUro@AshTewariMD
📺 Episode 2 of #BeyondtheBiopsy is live! @NitinYerram speaks with @KAttallaMD, of @MountSinaiNYC , on the evolving landscape of #prostate#biopsy and the growing shift from transrectal to transperineal techniques: https://t.co/Ng3TcO68CZ
🔎 They explore the technical differences between biopsy methods, why this long‑standing standard is now being re‑evaluated in modern practice, and more.
Dr. Kyrollis Attalla (@KAttallaMD) discusses the impact of MRI-guided biopsy in diagnosis and treatment decisions. #urology@IcahnMountSinai
https://t.co/JgZWHama1V
We're thrilled to announce @KAttallaMD as one of our speakers at the Fifth International Prostate Cancer Symposium and World Congress of Urologic Oncology this December in New York. Don't miss out on this global gathering of experts. Register today! https://t.co/kPYuUtVwnI
So proud to share the work of two incredibly talented dudes @KAttallaMD and @renzogdg whose work was just published in @CCR_AACR. https://t.co/KOOr5JEHW0